Noven to Present at Upcoming Investor Conferences

-- Noven Pharmaceuticals, Inc. (NASDAQ:NOVN) today announced that it is scheduled to present at two upcoming investor conferences. Robert Strauss, Noven’s President, CEO & Chairman, will present at the Lehman Brothers Eighth Annual Global Healthcare Conference in Miami Beach on Thursday, March 31 at 10:15 a.m. ET; and at the CIBC World Markets Annual Biotechnology & Specialty Pharmaceuticals Conference in New York on Monday, April 4 at 11:00 a.m. ET. Both presentations will be webcast live and accessible to the public at www.noven.com, and rebroadcasts will be available thereafter at the same site.

Noven Pharmaceuticals, Inc., headquartered in Miami, Florida, is a leading developer of advanced transdermal drug delivery technologies and prescription transdermal products. Noven’s prescription patches are sold in over 30 countries, and a range of new patches are being investigated and developed in collaboration with Novartis Pharma AG, Shire Pharmaceuticals Group plc, P&G Pharmaceuticals, Endo Pharmaceuticals Inc. and others. Noven is committed to expanding the universe of available transdermal therapies for the benefit of patients, partners and shareholders. See www.noven.com for additional information.

Contact:
Joseph C. Jones
Vice President – Corporate Affairs
Noven Pharmaceuticals, Inc.
305-253-1916